HARVARD BIOSCIENCE, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
HARVARD BIOSCIENCE, INC. (HBIO) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 0 shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2026-06-30 was 0.00 shares.
- HARVARD BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2026-03-31 was 0.00 shares.
- HARVARD BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-06-30 was 0.00 shares.
- HARVARD BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2025-03-31 was 0.00 shares.
- HARVARD BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2025 was 0.00 shares.
- HARVARD BIOSCIENCE, INC. incremental common shares attributable to dilutive effect of call options and warrants for fiscal 2024 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 6 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 12 month |
|---|---|---|---|
| 2026-06-30 | 0.00 shares 10-Q · filed 2026-08-11 | 0.00 shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | ||
| 2025-12-31 | 0.00 shares 10-K · filed 2026-03-13 | ||
| 2025-06-30 | 0.00 shares 10-Q · filed 2026-08-11 | 0.00 shares 10-Q · filed 2026-08-11 | |
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | ||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |